Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy

Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy

Glioblastomas (GBM) are the most aggressive tumors originating in the brain. Histopathologic features include circuitous, disorganized, and highly permeable blood vessels with intermittent blood flow. These features contribute to the inability to direct therapeutic agents to tumor cells. Known targe...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Cinzia Cocola, Valerio Magnaghi, Edoardo Abeni, Paride Pelucchi, Valentina Martino, Laura Vilardo, Eleonora Piscitelli, Arianna Consiglio, Giorgio Grillo, Ettore Mosca, Roberta Gualtierotti, Daniela Mazzaccaro, Gina La Sala, Chiara Di Pietro, Mira Palizban, Sabino Liuni, Giuseppina DePedro, Stefano Morara, Giovanni Nano, James Kehler, Burkhard Greve, Alessio Noghero, Daniela Marazziti, Federico Bussolino, Gianfranco Bellipanni, Igea D’Agnano, Martin Götte, Ileana Zucchi, Rolland Reinbold
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
cargo vesicle transport
angiogenesis and normalization of vascular network
tumor cell migration and adhesion
anticancer and antiangiogenic therapy
glioma
kinesin motor proteins
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Accès en ligne:https://doaj.org/article/75f0ce9fbf4943ef8b3abd80f17950d9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/75f0ce9fbf4943ef8b3abd80f17950d9

Documents similaires